Propensity ‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - August 14, 2018 Category: Endocrinology Authors: Julio Rosenstock MD , Yehuda Handelsman MD , Josep Vidal MD , F. Javier Ampudia Blasco MD , Francesco Giorgino MD , Minzhi Liu PhD , Riccardo Perfetti MD , Juris J. Meier MD Source Type: research